Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: Comparison of MR Imaging and FDG PET/CT1

Radiology

Volumn 249, Issue 1, 2008, Pages 203-211

  Comoretto, Maurizio ^a   Balestreri, Luca ^a   Borsatti, Eugenio ^a   Cimitan, Marino ^a   Franchin, Giovanni ^a   Lise, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; DIAGNOSTIC AGENT;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; WHOLE BODY CT; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 53749092480     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2491071753     Document Type: Article

References (38)

1. Chong VF, Fan YF. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 1997;202(2):463-470.
2. Chin SC, Fatterpekar G, Chen CY, Som PM. MR imaging of diverse manifestations of nasopharyngeal carcinomas. AJR Am J Roentgenol 2003; 180(6):1715-1722.
3. Shatzkes DR, Meltzer DE, Lee JA, Babb JS, Sanfilippo NJ, Holliday RA. Sclerosis of the pterygoid process in untreated patients with nasopharyngeal carcinoma. Radiology2006;239(1):181-186.
4. Franchin G, Vaccher E, Talamini R, et al. Naso-pharyngeal cancer WHO type II-III: monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy. Oral Oncol2002;38(2):137-144.
5. Taheri-Kadkhoda Z, Björk-Eriksson T, Johansson KA, Mercke C. Long-term treatment results for nasopharyngeal carcinoma: the Sahlgrenska University Hospital experience. Acta Oncol 2007;46(6):817-827.
6. Zheng XK, Chen LH, Wang QS, Wu FB. Influence of [18F] fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;65(4):1020-1025.
7. Koshy M, Paulino AC, Howell R, Schuster D, Halkar R, Davis LW. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 2005;27(6):494-502.
8. Sham JS, Wei WI, Kwan WH, Chan CW, Kwong WK, Choy D. Nasopharyngealcarcinoma: pattern of tumor regression after radiotherapy. Cancer 1990;65(2):216-220.
9. Low JS, Chua ET, Gao F, Wee JT. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma. Head Neck 2006;28(4):321-329.
10. Chen MY, Guo X, Wen WP, et al. Salvage surgical operation via endoscopic transnasal approach for local persistent or recurrent nasopharyngeal carcinoma [in Chinese]. Ai Zheng 2007;26(7):673-678.
11. Yen TC, Lin CY, Wang HM, et al. 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;65(5):1307-1314.
12. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18] fluoro-D-glucose PET and MR imaging diagnoses. Radiology1996;200(1):135-141.
13. Manavis J, Sivridis L, Koukourakis MI. Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of disease. Clin Imaging 2005;29(2):128-133.
14. Branstetter BF 4th, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235(2):580-586.
15. Tai CJ, Liang JA, Yang SN, Tsai MH, Lin CC, Kao CH. Detection of recurrent nasopharyngeal carcinomas with thallium-201 single-photon emission computed tomography in patients with indeterminate magnetic resonance imaging findings after radiotherapy. Head Neck 2003;25(3):227-231.
16. Yen RF, Hung RL, Pan MH, et al. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 2003;98(2):283-287.
17. Lau KY, Kan WK, Sze WM, et al. Magnetic resonance for T-staging of nasopharyngeal carcinoma: the most informative pair of sequences. Jpn J Clin Oncol 2004;34(4):171-175.
18. Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 2005;234(3):879-885.
19. van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177(2):379-384.
20. King AD, Ahuja AT, Leung SF, et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 2000;22(3):275-281.
21. Lu JC, Wei BQ, Chen WZ, et al. Staging of nasopharyngeal carcinoma investigated by magnetic resonance imaging. Radiother Oncol 2006;79(1):21-26.
22. Nishioka T, Shiga T, Shirato H, et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 2002;53(4):1051-1057.
23. Wu SX, Chua DT, Deng ML, et al. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007;69(3):761-769.
24. Wei WI, Mok VW. The management of neck metastases in nasopharyngeal cancer. Curr Opin Otolaryngol Head Neck Surg 2007;15(2):99-102.
25. Foo KF, Tan EH, Leong SS, et al. Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. Ann Oncol 2002;13(1):150-156.
26. Bass IS, Haller JO, Berdon WE, Barlow B, Carsen G, Khakoo Y. Nasopharyngeal carcinoma: clinical and radiographic findings in children. Radiology 1985;156(3):651-654.
27. Olmi P, Fallai C, Colagrande S, GiannardiG. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys 1995;32(3):795-800.
28. Yu DF, Zuo CT, Dai JZ, et al. Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy [in Chinese]. AiZheng2004;23(11 suppl):1538-1541.
29. Zhong JL, Liang BL, Ding ZX, et al. Significance of dynamic enhanced MRI in differential diagnosis of radiofibrosis and recurrent nasopharyngeal carcinoma at the basilar clivus [in Chinese]. Ai Zheng 2006;25(1):105-109.
30. Kristensen CA, Kjaer-Kristoffersen F, Sapru W, Berthelsen AK, Loft A, Specht L. Nasopharyngeal carcinoma: treatment planning with IMRT and 3D conformal radiotherapy. Acta Oncol 2007;46(2):214-220.
31. Chung NN, Ting LL, Hsu WC, Lui LT, Wang PM. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck 2004;26(3):241-246.
32. Rumboldt Z, Gordon L, Gordon L, Bonsall R, Ackermann S. Imaging in head and neck cancer. Curr TreatOptionsOncol2006;7(1):23-34.
33. Zhang GY, Hu WH, Liu LZ, et al. Comparison between PET/CT and MRI in diagnosing lymph node metastasis and N staging of nasopharyngeal carcinoma [in Chinese]. Zhonghua Zhong Liu Za Zhi 2006;28(5):381-384.
34. Su Y, Zhao C, Xie CM, et al. Evaluation of CT, MRI and PET-CT in detecting retropharyngeal lymph node metastasis in nasopharyngeal carcinoma [in Chinese]. Ai Zheng 2006;25(5):521-525.
35. LiuLZ, ZhangGY, Xie CM, LiuXW, CuiCY, LiL. Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: patterns of spread. Int J Radiat Oncol Biol Phys 2006;66(3):721-730.
36. Yen TC, Chang JT, Ng SH, et al. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med 2005;46(3):405-410.
37. Wang GH, Lau EW, Shakher R, et al. Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma [in Chinese]. Ai Zheng 2007;26(6):638-642.
38. Goerres GW, Von Schulthess GK, Hany TF. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR Am J Roentgenol 2002;179(5):1337-1343.